HEADER VIRAL PROTEIN/HYDROLASE 28-JAN-22 7WSA TITLE STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM TITLE 2 NEUTRALIZING ANTIBODY DEVELOPMENT COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: PROCESSED ANGIOTENSIN-CONVERTING ENZYME 2; COMPND 8 CHAIN: D; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: S, 2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ACE2, UNQ868/PRO1885; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS COVID-19, SPIKE GLYCOPROTEIN, VIRUS, VIRAL PROTEIN, ANTIBODY, VIRAL KEYWDS 2 PROTEIN-HYDROLASE COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR H.GUO,Y.GAO,X.JI,H.YANG REVDAT 1 01-JUN-22 7WSA 0 JRNL AUTH H.GUO,Y.GAO,T.LI,T.LI,Y.LU,L.ZHENG,Y.LIU,T.YANG,F.LUO, JRNL AUTH 2 S.SONG,W.WANG,X.YANG,H.C.NGUYEN,H.ZHANG,A.HUANG,A.JIN, JRNL AUTH 3 H.YANG,Z.RAO,X.JI JRNL TITL STRUCTURES OF OMICRON SPIKE COMPLEXES AND IMPLICATIONS FOR JRNL TITL 2 NEUTRALIZING ANTIBODY DEVELOPMENT. JRNL REF CELL REP V. 39 10770 2022 JRNL REFN ESSN 2211-1247 JRNL PMID 35477022 JRNL DOI 10.1016/J.CELREP.2022.110770 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.000 REMARK 3 NUMBER OF PARTICLES : 220680 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7WSA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-FEB-22. REMARK 100 THE DEPOSITION ID IS D_1300027339. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2 OMICRON SPIKE RBD REMARK 245 COMPLEX WITH HACE2 LOCAL REFINE; REMARK 245 OMICRON SPIKE RBD; HACE2 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : SARS-COV-2 OMICRON VARIANT REMARK 245 SPIKE PROTEIN ECTODOMAIN; HUMAN ANGIOTENSIN-CONVERTING ENZYME 2 REMARK 245 PD REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2800.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : SPOT SCAN REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR D 217 OD2 ASP D 225 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 525 CA - CB - SG ANGL. DEV. = 7.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 343 30.23 -95.13 REMARK 500 ALA A 352 63.38 -102.66 REMARK 500 ASP A 428 59.28 -94.04 REMARK 500 GLU D 35 -7.35 -59.55 REMARK 500 ILE D 484 -60.63 -97.24 REMARK 500 ASP D 509 61.46 60.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-32752 RELATED DB: EMDB REMARK 900 STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM REMARK 900 NEUTRALIZING ANTIBODY DEVELOPMENT DBREF 7WSA A 330 530 UNP P0DTC2 SPIKE_SARS2 330 530 DBREF 7WSA D 19 613 UNP Q9BYF1 ACE2_HUMAN 19 613 SEQADV 7WSA ASP A 339 UNP P0DTC2 GLY 339 VARIANT SEQADV 7WSA LEU A 371 UNP P0DTC2 SER 371 VARIANT SEQADV 7WSA PRO A 373 UNP P0DTC2 SER 373 VARIANT SEQADV 7WSA PHE A 375 UNP P0DTC2 SER 375 VARIANT SEQADV 7WSA ASN A 417 UNP P0DTC2 LYS 417 VARIANT SEQADV 7WSA LYS A 440 UNP P0DTC2 ASN 440 VARIANT SEQADV 7WSA SER A 446 UNP P0DTC2 GLY 446 VARIANT SEQADV 7WSA ASN A 477 UNP P0DTC2 SER 477 VARIANT SEQADV 7WSA LYS A 478 UNP P0DTC2 THR 478 VARIANT SEQADV 7WSA ALA A 484 UNP P0DTC2 GLU 484 VARIANT SEQADV 7WSA ARG A 493 UNP P0DTC2 GLN 493 VARIANT SEQADV 7WSA SER A 496 UNP P0DTC2 GLY 496 VARIANT SEQADV 7WSA ARG A 498 UNP P0DTC2 GLN 498 VARIANT SEQADV 7WSA TYR A 501 UNP P0DTC2 ASN 501 VARIANT SEQADV 7WSA HIS A 505 UNP P0DTC2 TYR 505 VARIANT SEQRES 1 A 201 PRO ASN ILE THR ASN LEU CYS PRO PHE ASP GLU VAL PHE SEQRES 2 A 201 ASN ALA THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG SEQRES 3 A 201 LYS ARG ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU SEQRES 4 A 201 TYR ASN LEU ALA PRO PHE PHE THR PHE LYS CYS TYR GLY SEQRES 5 A 201 VAL SER PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN SEQRES 6 A 201 VAL TYR ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL SEQRES 7 A 201 ARG GLN ILE ALA PRO GLY GLN THR GLY ASN ILE ALA ASP SEQRES 8 A 201 TYR ASN TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL SEQRES 9 A 201 ILE ALA TRP ASN SER ASN LYS LEU ASP SER LYS VAL SER SEQRES 10 A 201 GLY ASN TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER SEQRES 11 A 201 ASN LEU LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE SEQRES 12 A 201 TYR GLN ALA GLY ASN LYS PRO CYS ASN GLY VAL ALA GLY SEQRES 13 A 201 PHE ASN CYS TYR PHE PRO LEU ARG SER TYR SER PHE ARG SEQRES 14 A 201 PRO THR TYR GLY VAL GLY HIS GLN PRO TYR ARG VAL VAL SEQRES 15 A 201 VAL LEU SER PHE GLU LEU LEU HIS ALA PRO ALA THR VAL SEQRES 16 A 201 CYS GLY PRO LYS LYS SER SEQRES 1 D 595 SER THR ILE GLU GLU GLN ALA LYS THR PHE LEU ASP LYS SEQRES 2 D 595 PHE ASN HIS GLU ALA GLU ASP LEU PHE TYR GLN SER SER SEQRES 3 D 595 LEU ALA SER TRP ASN TYR ASN THR ASN ILE THR GLU GLU SEQRES 4 D 595 ASN VAL GLN ASN MET ASN ASN ALA GLY ASP LYS TRP SER SEQRES 5 D 595 ALA PHE LEU LYS GLU GLN SER THR LEU ALA GLN MET TYR SEQRES 6 D 595 PRO LEU GLN GLU ILE GLN ASN LEU THR VAL LYS LEU GLN SEQRES 7 D 595 LEU GLN ALA LEU GLN GLN ASN GLY SER SER VAL LEU SER SEQRES 8 D 595 GLU ASP LYS SER LYS ARG LEU ASN THR ILE LEU ASN THR SEQRES 9 D 595 MET SER THR ILE TYR SER THR GLY LYS VAL CYS ASN PRO SEQRES 10 D 595 ASP ASN PRO GLN GLU CYS LEU LEU LEU GLU PRO GLY LEU SEQRES 11 D 595 ASN GLU ILE MET ALA ASN SER LEU ASP TYR ASN GLU ARG SEQRES 12 D 595 LEU TRP ALA TRP GLU SER TRP ARG SER GLU VAL GLY LYS SEQRES 13 D 595 GLN LEU ARG PRO LEU TYR GLU GLU TYR VAL VAL LEU LYS SEQRES 14 D 595 ASN GLU MET ALA ARG ALA ASN HIS TYR GLU ASP TYR GLY SEQRES 15 D 595 ASP TYR TRP ARG GLY ASP TYR GLU VAL ASN GLY VAL ASP SEQRES 16 D 595 GLY TYR ASP TYR SER ARG GLY GLN LEU ILE GLU ASP VAL SEQRES 17 D 595 GLU HIS THR PHE GLU GLU ILE LYS PRO LEU TYR GLU HIS SEQRES 18 D 595 LEU HIS ALA TYR VAL ARG ALA LYS LEU MET ASN ALA TYR SEQRES 19 D 595 PRO SER TYR ILE SER PRO ILE GLY CYS LEU PRO ALA HIS SEQRES 20 D 595 LEU LEU GLY ASP MET TRP GLY ARG PHE TRP THR ASN LEU SEQRES 21 D 595 TYR SER LEU THR VAL PRO PHE GLY GLN LYS PRO ASN ILE SEQRES 22 D 595 ASP VAL THR ASP ALA MET VAL ASP GLN ALA TRP ASP ALA SEQRES 23 D 595 GLN ARG ILE PHE LYS GLU ALA GLU LYS PHE PHE VAL SER SEQRES 24 D 595 VAL GLY LEU PRO ASN MET THR GLN GLY PHE TRP GLU ASN SEQRES 25 D 595 SER MET LEU THR ASP PRO GLY ASN VAL GLN LYS ALA VAL SEQRES 26 D 595 CYS HIS PRO THR ALA TRP ASP LEU GLY LYS GLY ASP PHE SEQRES 27 D 595 ARG ILE LEU MET CYS THR LYS VAL THR MET ASP ASP PHE SEQRES 28 D 595 LEU THR ALA HIS HIS GLU MET GLY HIS ILE GLN TYR ASP SEQRES 29 D 595 MET ALA TYR ALA ALA GLN PRO PHE LEU LEU ARG ASN GLY SEQRES 30 D 595 ALA ASN GLU GLY PHE HIS GLU ALA VAL GLY GLU ILE MET SEQRES 31 D 595 SER LEU SER ALA ALA THR PRO LYS HIS LEU LYS SER ILE SEQRES 32 D 595 GLY LEU LEU SER PRO ASP PHE GLN GLU ASP ASN GLU THR SEQRES 33 D 595 GLU ILE ASN PHE LEU LEU LYS GLN ALA LEU THR ILE VAL SEQRES 34 D 595 GLY THR LEU PRO PHE THR TYR MET LEU GLU LYS TRP ARG SEQRES 35 D 595 TRP MET VAL PHE LYS GLY GLU ILE PRO LYS ASP GLN TRP SEQRES 36 D 595 MET LYS LYS TRP TRP GLU MET LYS ARG GLU ILE VAL GLY SEQRES 37 D 595 VAL VAL GLU PRO VAL PRO HIS ASP GLU THR TYR CYS ASP SEQRES 38 D 595 PRO ALA SER LEU PHE HIS VAL SER ASN ASP TYR SER PHE SEQRES 39 D 595 ILE ARG TYR TYR THR ARG THR LEU TYR GLN PHE GLN PHE SEQRES 40 D 595 GLN GLU ALA LEU CYS GLN ALA ALA LYS HIS GLU GLY PRO SEQRES 41 D 595 LEU HIS LYS CYS ASP ILE SER ASN SER THR GLU ALA GLY SEQRES 42 D 595 GLN LYS LEU PHE ASN MET LEU ARG LEU GLY LYS SER GLU SEQRES 43 D 595 PRO TRP THR LEU ALA LEU GLU ASN VAL VAL GLY ALA LYS SEQRES 44 D 595 ASN MET ASN VAL ARG PRO LEU LEU ASN TYR PHE GLU PRO SEQRES 45 D 595 LEU PHE THR TRP LEU LYS ASP GLN ASN LYS ASN SER PHE SEQRES 46 D 595 VAL GLY TRP SER THR ASP TRP SER PRO TYR HET NAG A1301 14 HET NAG D 701 14 HET NAG D 702 14 HET NAG D 703 14 HET NAG D 704 14 HET NAG D 705 14 HET NAG D 706 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 7(C8 H15 N O6) HELIX 1 AA1 PRO A 337 ASN A 343 1 7 HELIX 2 AA2 TYR A 365 ASN A 370 1 6 HELIX 3 AA3 PRO A 384 ASP A 389 5 6 HELIX 4 AA4 GLY A 416 ASN A 422 1 7 HELIX 5 AA5 SER A 438 SER A 443 1 6 HELIX 6 AA6 THR D 20 THR D 52 1 33 HELIX 7 AA7 THR D 55 GLN D 81 1 27 HELIX 8 AA8 ASN D 90 GLN D 101 1 12 HELIX 9 AA9 ASN D 103 LEU D 108 5 6 HELIX 10 AB1 SER D 109 THR D 129 1 21 HELIX 11 AB2 GLY D 147 SER D 155 1 9 HELIX 12 AB3 ASP D 157 ASN D 194 1 38 HELIX 13 AB4 ASP D 198 GLY D 205 1 8 HELIX 14 AB5 ASP D 206 GLU D 208 5 3 HELIX 15 AB6 GLY D 220 TYR D 252 1 33 HELIX 16 AB7 HIS D 265 LEU D 267 5 3 HELIX 17 AB8 TRP D 275 TYR D 279 5 5 HELIX 18 AB9 VAL D 293 GLN D 300 1 8 HELIX 19 AC1 ASP D 303 VAL D 318 1 16 HELIX 20 AC2 THR D 324 SER D 331 1 8 HELIX 21 AC3 THR D 365 TYR D 385 1 21 HELIX 22 AC4 ALA D 386 GLN D 388 5 3 HELIX 23 AC5 PRO D 389 ARG D 393 5 5 HELIX 24 AC6 GLY D 399 ALA D 413 1 15 HELIX 25 AC7 THR D 414 ILE D 421 1 8 HELIX 26 AC8 ASP D 431 VAL D 447 1 17 HELIX 27 AC9 GLY D 448 GLY D 466 1 19 HELIX 28 AD1 PRO D 469 ASP D 471 5 3 HELIX 29 AD2 GLN D 472 ILE D 484 1 13 HELIX 30 AD3 ASP D 499 SER D 502 5 4 HELIX 31 AD4 LEU D 503 ASN D 508 1 6 HELIX 32 AD5 PHE D 512 ALA D 533 1 22 HELIX 33 AD6 PRO D 538 CYS D 542 5 5 HELIX 34 AD7 SER D 547 ARG D 559 1 13 HELIX 35 AD8 PRO D 565 GLY D 575 1 11 HELIX 36 AD9 VAL D 581 PHE D 588 1 8 HELIX 37 AE1 PHE D 588 ASN D 599 1 12 SHEET 1 AA1 5 ASN A 354 ILE A 358 0 SHEET 2 AA1 5 ASN A 394 ILE A 402 -1 O ALA A 397 N LYS A 356 SHEET 3 AA1 5 TYR A 508 GLU A 516 -1 O TYR A 508 N ILE A 402 SHEET 4 AA1 5 GLY A 431 ASN A 437 -1 N ILE A 434 O VAL A 511 SHEET 5 AA1 5 THR A 376 TYR A 380 -1 N TYR A 380 O GLY A 431 SHEET 1 AA2 2 LEU A 452 ARG A 454 0 SHEET 2 AA2 2 LEU A 492 SER A 494 -1 O ARG A 493 N TYR A 453 SHEET 1 AA3 2 TYR A 473 GLN A 474 0 SHEET 2 AA3 2 CYS A 488 TYR A 489 -1 O TYR A 489 N TYR A 473 SHEET 1 AA4 2 LEU D 262 PRO D 263 0 SHEET 2 AA4 2 VAL D 487 VAL D 488 1 O VAL D 488 N LEU D 262 SHEET 1 AA5 2 THR D 347 GLY D 352 0 SHEET 2 AA5 2 ASP D 355 LEU D 359 -1 O ARG D 357 N TRP D 349 SSBOND 1 CYS A 336 CYS A 361 1555 1555 2.03 SSBOND 2 CYS A 379 CYS A 432 1555 1555 2.04 SSBOND 3 CYS A 391 CYS A 525 1555 1555 2.02 SSBOND 4 CYS A 480 CYS A 488 1555 1555 2.03 SSBOND 5 CYS D 133 CYS D 141 1555 1555 2.03 SSBOND 6 CYS D 530 CYS D 542 1555 1555 2.03 LINK ND2 ASN A 343 C1 NAG A1301 1555 1555 1.44 LINK ND2 ASN D 53 C1 NAG D 701 1555 1555 1.44 LINK ND2 ASN D 90 C1 NAG D 702 1555 1555 1.45 LINK ND2 ASN D 103 C1 NAG D 703 1555 1555 1.44 LINK ND2 ASN D 322 C1 NAG D 704 1555 1555 1.44 LINK ND2 ASN D 432 C1 NAG D 705 1555 1555 1.44 LINK ND2 ASN D 546 C1 NAG D 706 1555 1555 1.44 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000